About
Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP.
Key Metrics
as of Sep 2026Market Cap337 Cr
P/E22.90
Div Yield0.00 %
Book Value₹79.10
52w High₹103.00
52w Low₹60.40
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Mar 2025 |
|---|---|---|---|---|
| Sales | 100.94 | 134.05 | 52.24 | 23.47 |
| Expenses | 88.69 | 123.86 | 48.69 | 19.29 |
| Operating Profit | 12.25 | 10.19 | 3.55 | 4.18 |
| OPM % | 12.14 | 7.60 | 6.80 | 17.81 |
| Other Income | 0.14 | 0.10 | 0.04 | 0.04 |
| Depreciation | 0.86 | 0.86 | 0.12 | 0.10 |
| Interest | 1.18 | 1.09 | 0.33 | 0.27 |
| Profit before tax | 10.35 | 8.34 | 3.14 | 3.85 |
| Tax % | 8.99 | 7.91 | 24.52 | 28.57 |
| Net Profit | 9.42 | 7.68 | 2.36 | 2.74 |
| EPS in Rs | 2.15 | 1.82 | 2.19 | 2.79 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 |
|---|---|---|
| Sales | 249.00 | 64.00 |
| Expenses | 228.00 | 51.00 |
| Operating Profit | 21.00 | 13.00 |
| OPM % | 8.00 | 20.00 |
| Other Income | 0.00 | 0.00 |
| Interest | 2.00 | 1.00 |
| Depreciation | 1.00 | 0.00 |
| Profit before tax | 18.00 | 12.00 |
| Tax % | 17.00 | 25.00 |
| Net Profit | 15.00 | 9.00 |
| EPS in Rs | 3.48 | 9.08 |
| Dividend Payout % | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 |
|---|---|---|
| Equity Capital | 42.00 | 10.00 |
| Reserves | 292.00 | 26.00 |
| Borrowings | 50.00 | 13.00 |
| Other Liabilities | 135.00 | 14.00 |
| Total Liabilities | 518.00 | 63.00 |
| Fixed Assets | 268.00 | 11.00 |
| CWIP | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 |
| Other Assets | 251.00 | 52.00 |
| Total Assets | 518.00 | 63.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 |
|---|---|---|
| Cash from Operating Activity | -18.00 | -13.00 |
| Cash from Investing Activity | -2.00 | -8.00 |
| Cash from Financing Activity | 3.00 | 3.00 |
| Net Cash Flow | -17.00 | -17.00 |
| Free Cash Flow | -19.00 | -18.00 |
| CFO/OP % | -80.00 | -96.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 |
|---|---|---|
| Debtor Days | 229.00 | 157.00 |
| Inventory Days | 113.00 | 112.00 |
| Days Payable | 206.00 | 82.00 |
| Cash Conversion Cycle | 135.00 | 187.00 |
| Working Capital Days | 114.00 | 97.00 |
| ROCE % | 9.00 | — |
Corporate Actions
No corporate actions recorded.